Info

🌱 來自: aya all

revumenib

1. Issa GC, Ibrahim Aldoss, DiPersio JF, et al. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature. 2023;615(7954):920-924. doi:https://doi.org/10.1038/s41586-023-05812-3 ‌